Text of What CIRM Had to Say About its New Priorities for $3.9 Billion

Sep 26, 2024

∙ Paid

Earlier this month, the California Stem Cell Report asked CIRM to respond to a series of questions concerning the agency’s new priorities.

Here are the questions and text of responses from CIRM:

How do the new priorities differ from what has happened over the last 20 years?

From Rosa Canet-Avilés, chief scientific officer at CIRM and leader of the priorities review, “Over the last 20 years, CIRM has contributed greatly to regenerative medicine through broad funding initiatives. With the Strategic Allocation Framework (SAF) under Proposition 14. The new priorities differ in key ways:

Keep reading with a 7-day free trial

Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.